Strategy
MSTR
MARA Holdings
MARA
NVIDIA
NVDA
Tesla
TSLA
Coinbase
COIN
US Stock MarketDetailed Quotes
ANTX AN2 Therapeutics
- 1.140
- +0.030+2.70%
Close Feb 28 16:00 ET
- 1.140
- 0.0000.00%
Post 20:01 ET
34.06MMarket Cap-0.57P/E (TTM)
1.140High1.093Low57.12KVolume1.120Open1.110Pre Close64.62KTurnover0.31%Turnover RatioLossP/E (Static)29.88MShares3.88052wk High0.39P/B20.73MFloat Cap0.87052wk Low--Dividend TTM18.18MShs Float23.580Historical High--Div YieldTTM4.23%Amplitude0.870Historical Low1.131Avg Price1Lot Size
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
AN2 Therapeutics Stock Forum
Can AN2's Strategic Pivot Save Its MAC Lung Disease Treatment? Phase 2 Data Offers Hope
I am in here for swing play. Chart looks good and insiders have been loading.
AN2 Therapeutics Receives Continuation Grant to Discover Novel Boron Based Therapies for Tuberculosis (Caused by Mycobacterium Tuberculosis) and Malaria
Phase 3 continues for 97 patients enrolled before the voluntary enrollment pause; lifting of the Phase 3 enrollment pause to be determined after review of unblinded Phase 2 data and discussions with the FDA
No comment yet